GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 817 filers reported holding GLAXOSMITHKLINE PLC in Q3 2020. The put-call ratio across all filers is 0.91 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $880,000 | +5.6% | 20,215 | +5.7% | 0.01% | +16.7% |
| Q1 2022 | $833,000 | +14.3% | 19,132 | +15.7% | 0.01% | +20.0% |
| Q4 2021 | $729,000 | +15.3% | 16,537 | +0.1% | 0.01% | +25.0% |
| Q3 2021 | $632,000 | -4.2% | 16,521 | -0.4% | 0.00% | -20.0% |
| Q2 2021 | $660,000 | +5.4% | 16,590 | -5.5% | 0.01% | 0.0% |
| Q1 2021 | $626,000 | -0.3% | 17,553 | +2.8% | 0.01% | 0.0% |
| Q4 2020 | $628,000 | -13.4% | 17,076 | -11.3% | 0.01% | -28.6% |
| Q3 2020 | $725,000 | -14.3% | 19,250 | -7.1% | 0.01% | -12.5% |
| Q2 2020 | $846,000 | -6.3% | 20,723 | -13.1% | 0.01% | -27.3% |
| Q1 2020 | $903,000 | -16.4% | 23,850 | +3.7% | 0.01% | +10.0% |
| Q4 2019 | $1,080,000 | +2.0% | 23,000 | -7.3% | 0.01% | -9.1% |
| Q3 2019 | $1,059,000 | -6.0% | 24,823 | -11.9% | 0.01% | -15.4% |
| Q2 2019 | $1,127,000 | -5.5% | 28,177 | -1.2% | 0.01% | -7.1% |
| Q1 2019 | $1,192,000 | +6.5% | 28,531 | -2.6% | 0.01% | 0.0% |
| Q4 2018 | $1,119,000 | -9.2% | 29,295 | -4.5% | 0.01% | -6.7% |
| Q3 2018 | $1,232,000 | -12.7% | 30,667 | -12.5% | 0.02% | -16.7% |
| Q2 2018 | $1,412,000 | -42.8% | 35,034 | -44.6% | 0.02% | +12.5% |
| Q1 2018 | $2,470,000 | +85.6% | 63,194 | +68.4% | 0.02% | -5.9% |
| Q4 2017 | $1,331,000 | -18.7% | 37,525 | -7.0% | 0.02% | -22.7% |
| Q3 2017 | $1,637,000 | -9.6% | 40,336 | -3.9% | 0.02% | -12.0% |
| Q2 2017 | $1,811,000 | +4.2% | 41,977 | +1.8% | 0.02% | 0.0% |
| Q1 2017 | $1,738,000 | +8.4% | 41,228 | -1.0% | 0.02% | +4.2% |
| Q4 2016 | $1,604,000 | -22.4% | 41,636 | -13.1% | 0.02% | -25.0% |
| Q3 2016 | $2,068,000 | -4.0% | 47,940 | -3.6% | 0.03% | -5.9% |
| Q2 2016 | $2,155,000 | +6.9% | 49,708 | +0.0% | 0.03% | +3.0% |
| Q1 2016 | $2,015,000 | +1.9% | 49,690 | +1.4% | 0.03% | 0.0% |
| Q4 2015 | $1,978,000 | +4.9% | 49,026 | -0.1% | 0.03% | +3.1% |
| Q3 2015 | $1,886,000 | -10.2% | 49,055 | -2.7% | 0.03% | -3.0% |
| Q2 2015 | $2,100,000 | -14.3% | 50,413 | -5.0% | 0.03% | -13.2% |
| Q1 2015 | $2,449,000 | +6.4% | 53,077 | -1.4% | 0.04% | +5.6% |
| Q4 2014 | $2,301,000 | -30.0% | 53,843 | -24.7% | 0.04% | -33.3% |
| Q3 2014 | $3,288,000 | -11.7% | 71,509 | +2.7% | 0.05% | -11.5% |
| Q2 2014 | $3,724,000 | +1.8% | 69,633 | +1.7% | 0.06% | -1.6% |
| Q1 2014 | $3,657,000 | +3.4% | 68,453 | +3.3% | 0.06% | +1.6% |
| Q4 2013 | $3,538,000 | +52.6% | 66,259 | +43.4% | 0.06% | +45.2% |
| Q3 2013 | $2,318,000 | -1.2% | 46,191 | -1.6% | 0.04% | -4.5% |
| Q2 2013 | $2,345,000 | +6.4% | 46,925 | -0.1% | 0.04% | +2.3% |
| Q1 2013 | $2,204,000 | – | 46,978 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
| Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
| KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
| Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
| Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
| EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
| Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
| Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
| CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
| CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |